Journal
AMERICAN JOURNAL OF HUMAN GENETICS
Volume 92, Issue 2, Pages 265-270Publisher
CELL PRESS
DOI: 10.1016/j.ajhg.2012.12.003
Keywords
-
Categories
Funding
- Retina France
- Clinical Research Hospital Program of the French Ministry of Health [PHRC 09 109 01]
- Academy of Medical Sciences/Health Foundation
- VICTA (Visually Impaired Children Taking Action)
- MACS (Microphthalmia and Anophthalmia Children's Society)
- Hampshire and Isle of Wight Comprehensive Local Research Network
Ask authors/readers for more resources
Anophthalmia and microphthalmia (A/M) are early-eye-development anomalies resulting in absent or small ocular globes, respectively. A/M anomalies occur in syndromic or nonsyndromic forms. They are genetically heterogeneous, some mutations in some genes being responsible for both anophthalmia and microphthalmia. Using a combination of homozygosity mapping, exome sequencing, and Sanger sequencing, we identified homozygosity for one splice-site and two missense mutations in the gene encoding the A3 isoform of the aldehyde dehydrogenase 1 (ALDH1A3) in three consanguineous families segregating A/M with occasional orbital cystic, neurological, and cardiac anomalies. ALDH1A3 is a key enzyme in the formation of a retinoic acid gradient along the dorso-ventral axis during early eye development. Transitory expression of mutant ALDH1A3 open reading frames showed that both missense mutations reduce the accumulation of the enzyme, potentially leading to altered retinoic acid synthesis. Although the role of retinoic acid signaling in eye development is well established, our findings provide genetic evidence of a direct link between retinoic-acid-synthesis dysfunction and early-eye-development anomalies in humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available